RetroSense Therapeutics Announces Notice of Allowance for New U.S. Patent ApplicationRetroSense Therapeutics, a biotechnology company dedicated to developing gene therapy approaches to vision restoration, announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for U.S. patent application (No. 12,299,574), which broadly covers methods of restoring visual responses with a variety of optogenetic compounds.
HR Notices From October 4The latest staffing, leadership and boardroom news from Michigan's technology-focused companies, institutions and groups
RetroSense Therapeutics Completes pre-IND Meeting for RST-001RetroSense Therapeutics, a gene therapy company dedicated to vision restoration, announced completion of a pre-IND meeting with the Center for Biological Evaluation and Research division of the FDA that took place on May 22 regarding RetroSense’s lead product candidate, RST-001 for vision restoration in retinal degenerative conditions.
HR Notices From April 19The latest staffing, leadership and boardroom news from Michigan's technology-focused companies, institutions and groups.
Wayne State Gets Licenses For Breakthrough Approaches to Vision RestorationRetroSense Therapeutics LLC, a Michigan-based company, announced that it has executed its exclusive, worldwide option and signed a license agreement for novel gene-therapy approaches for treating blindness developed at Wayne State University's School of Medicine.

More From CBS Detroit

Best Places For Paczki In DetroitFat Tuesday is less than a week away! Here's where to find the best paczki in town.
Best Ice Cream Shops In Metro DetroitIt's getting warm outside! Take advantage of it.
Best Hiking Trails In Metro DetroitGet out there and enjoy this unseasonably warm weather!

Watch & Listen